Improvement in 2-year survival for ventricular assist device patients after implementation of an intensive surveillance protocol

Journal of Heart and Lung Transplantation

Volumn 30, Issue 8, 2011, Pages 879-887

  Pamboukian, Salpy V ^a   Tallaj, José A ^a   Brown, Robert N ^b   Holman, William L ^b   Blood, Margaret ^a   George, James F ^b   Costanzo, Maria Rosa ^c   Cadeiras, Martin ^a   Smallfield, Melissa C ^a   McGiffin, David C ^b   Kirklin, James K ^b  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c Edward Heart Hospital   (United States)

Author keywords

care; disease management; outpatient; survival; ventricular assist device

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HEART ASSIST DEVICE; HUMAN; INTENSIVE SURVEILLANCE PROTOCOL; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; RISK FACTOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; ALGORITHMS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; KAPLAN-MEIER ESTIMATE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SENTINEL SURVEILLANCE; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79959997060     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2011.03.001     Document Type: Article

References (13)

1. E.H. Blackstone, D.C. Naftel, and M.E. Turner Jr The decomposition of time-varying hazard into phases, each incorporating a separate stream of concomitant information J Am Stat Assoc 81 1986 615 624
2. E.A. Rose, A.C. Gelijns, A.J. Muskowitz Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group Long term mechanical left ventricular assistance for end-stage heart failure N Engl J Med 345 2001 1435 1443
3. J.W. Long, A.H. Healy, and B.Y. Rasmusson Improving outcomes with long-term "destination" therapy using left ventricular assist devices J Thorac Cardiovasc Surg 135 2008 1353 1360
4. K. Lietz, J.W. Long, and A.G. Kfoury Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era Implications for patient selection Circulation 116 2007 497 505 (Pubitemid 47450258)
5. J.C. Matthews, T.M. Koelling, F.D. Pagani, and K.D. Aaronson The right ventricular failure risk score: a preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates J Am Coll Cardiol 51 2008 2163 2172 (Pubitemid 351713685)
6. W.E. Richenbacher, Y. Naka, E.P. Raines, O.H. Frazier, G.S. Couper, and F.D. Pagani Surgical management of patients in the REMATCH trial Ann Thorac Surg 75 6 Suppl 2003 S86 S92
7. W.L. Holman, S.V. Pamboukian, and S.C. Bellot Use of an intraperitoneal ventricular assist device with polytetrafluoroethylene barrier decreases infections J Heart Lung Transplant 27 2008 268 271 (Pubitemid 351375111)
8. W.L. Holman, S.J. Park, and J.W. Long Infection in permanent circulatory support: experience from the REMATCH trial J Heart Lung Transplant 23 2004 1359 1365 (Pubitemid 40018157)
9. M.S. Slaughter, J.G. Rogers, and C.A. Milano Advanced heart failure treated with continuous flow device N Engl J Med 361 2009 2241 2251
10. Advanced practice guidelines for HeartMate destination therapy Vol 1 2004 Thoratec Pleasanton, CA
11. Advanced practice guidelines for HeartMate destination therapy Vol 2 2004 Thoratec Pleasanton, CA
12. Patient management for the HeartMate II LVAD 2007 Thoratec Pleasanton, CA
13. J. Martin, O. Friesewinkel, and C. Benk Improved durability of the HeartMate XVE left ventricular assist device provides safe mechanical support up to 1 year but is associated with high risk of device failure in the second year J Heart Lung Transplant 25 2006 384 390